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                                   INTRODUCTION 
 
 
        Human immune deficiency virus  infection was first identified  in the 
year 1986 at Madras. Subsequently cases of HIV infection and AIDS identified 
all over India.HIV virus when infects a person over time causes AIDS(Acquired 
Immuno Deficiency Syndrome) .AIDS is a condition which causes progressive 
failure of the body’s immune system allows life-threatening opportunistic 
infections and certain cancers to thrive. There are numerous clinical 
manifestations of AIDS. In India there are many studies dealing with various 
aspects of AIDS cases. Eventhough few studies available on various organ 
involvement in HIV infection and AIDS, they do not describe renal involvement 
in AIDS cases. So I hereby made an attempt  to study renal and electrolyte 
disturbances  in  HIV affected   individuals. 
 
 
 
 
  INCIDENCE AND PREVALENCE IN INDIA:  
    
 INDIA is world’s third largest population suffering from HIV/AIDS. In  our 
country ,as per 2015,there are 2.1 million people living with HIV. Adult (15–49 
years) HIV prevalence is estimated as 0.3% .There are 68,000  people died of 
AIDS related illnesses in India  in 2015.There occurs about 86,000 new HIV 
infections by the year 2015. Overall India’s HIV epidemic is falling down.HIV 
prevalence in India varies geographically. The 5 states with highest prevalence 
are Nagaland, Mizoram, Manipur,  Andhra Pradesh and Karnataka. 
 
 
 
 
 
 
 
  
 
                                        AIMS AND OBJECTIVES 
 
  1) To find out the prevalence of Renal and electrolyte disturbances in 
Patients with HIV irrespective of ART. 
 
2)To explore the mechanism for renal involvement through literature 
 
 
 
 
 
                               
 
                              REVIEW OF LITERATURE 
 HISTORY AND PROBLEM STATEMENT 
                  AIDS (Acquired immunodeficiency  syndrome), recognised as an 
emerging disease in early 1980s.It then has  evolved from a mysterious illness 
to a global pandemic by infecting tens of million in less than twenty years. In 
1981, AIDS was recognised in US recognised that HIV was the causative agent 
for AIDS.  
           According to estimates by WHO at the end of 2015, around 36.7 million 
people were living with HIV worldwide  and around 11.7 million people had 
access to antiretroviral therapy in low and middle income countries. Over 28  
million people are eligible for antiretroviral therapy, under WHO. 
TYPES OF HIV EPIDEMICS 
 WHO and UNAIDS define the different types of HIV epidemics as below. 
Low level 
epidemics 
HIV prevalence  not consistently exceeded more than 5% 
in any defined subpopulation 
Concentrated 
epidemics 
HIV prevalence   consistently exceeded more than 5% in 
atleast one subpopulation but < 1% in pregnant women. 
Generalised HIV in HIV prevalence  consistently exceeded more than 5% in 
epidemics any defined subpopulation and > 1% in pregnant women. 
 
      
 HIV PREVALENCE STATEMENT IN (SEAR) COUNTRIES,2007  
COUNTRY ESTIMATED NUMBER OF 
PLHA 
PERCENTAGE OF ADULT 
POPULATION INFECTED  
WITH  HIV 
BANGLADESH 12,000 <0.1%. 
BHUTAN <500 <0.1%. 
INDIA 24,00,000   0.3% 
INDONESIA 2,70,000   0.2% 
MALDIVES <100   0.1% 
MYANMAR 2,40,000   0.7% 
NEPAL 70,000   0.5% 
SRILANKA 3,800  <0.1% 
TAILAND 6,10,000   1.4% 
 
  HIV PREVALENCE IN INDIA 
Based on  sentinel surveillance  data, HIV prevalence classified into three 
groups. 
GROUP I – HIGH PREVALENCE STATES 
                    >5% in high risk groups and 1% or > 1% in pregnant women 
                    -Tamilnadu, Maharastra, Karnataka.  
                    -Andhra pradesh, Manipur, Nagaland. 
GROUP II - MODERATE PREVALENCE STATES 
                     >5% in high risk groups and <1% in pregnant women 
                    - Gujarat, Goa, Pondicherry. 
GROUP III -  LOW PREVALENCE STATES 
                         <5% in high risk groups and <1% in pregnant women                     
-other states. 
DEFINITION AND CLASSIFICATION 
            The current CDC (Center for disease control and prevention) classified 
the HIV infected person based on clinical condition and CD4 cell count . 
            HIV patient  is will  have AIDS when the CD4 count <200/microlitre 
irrespective of presence of  symptoms, signs and opportunistic infections. 
CD4+ T cell 
count (per µL), 
Category A – 
asymptomatic/ 
acute HIV/ PGL 
Category B – 
symptomatic  
Category C – 
AIDS indicators 
>500 A1 B1 C1 
200 – 400 A2 B2 C2 
<200 A3 B3 C3 
 
CATEGORY A : consists of  patients with one or more  of  the  following 
conditions , but conditions enumerated under category B or C must not have 
occurred. These include : 
Asymptomatic infection 
Generalised lymphnode enlargement (present persistently) 
Acute HIV infection with associated  illness or history of acute HIV 
infection. 
 
CATEGORY B:  Includes Patients with one or more of   following  conditions, 
but those under category C must not have occurred plus  the condition is related 
to HIV or defect in cell mediated immunity. These include
[11]
 :       
 Bacillary angiomatosis, 
 Oral thrush, 
 Vulvovaginal candidiasis  recurrent/ non responsive to treatment, 
 Cervical dysplasia/ carcinoma in situ, 
 Fever/ diarrhoea > 1 month, 
 Oral hairy leukoplakia, 
 
 >1 episode/ >1 dermatome – Herpes zoster, 
 Idiopathic thrombocytopenic purpura, 
 Listeria infection, 
 PID like tubo ovarian abscess, 
 Peripheral neuropathy. 
 
Category c-AIDS defining illness 
 Invasive candidiasis (esophagus, trachea, lung or bronchi), 
 Invasive cervical malignancy, 
 Coccidioidomycosis, 
 Cryptococcosis,  
  Chronic intestinal Cryptosporidiosis / Isospora infection, 
 CMV retinitis, 
 HIV encephalopathy, 
 Herpes simplex infections ( bronchitis, pneumonia, esophagitis), 
 Histoplasmosis,  
 Kaposi sarcoma, 
 Primary CNS lymphoma, 
 Burkitt’s  lymphoma, 
 
 Pulmonary or extrapulmonary TB, 
 Mycobacterium Avium Complex infection. 
        Pneumocystis carinii pneumonia, 
 Progressive multifocal leukoencephalopathy (PML), 
 CNS toxoplasmosis, 
 AIDS cachexia, 
 Recurrent pneumonia/ Salmonella sepsis. 
 
HIV VIRUS 
HIV virus is classified under  family of retroviridae and subfamily of lentivirus. 
Two subtypes of HIV virus have been identified. HIV 1 is  most common 
subtype in worldwide. HIV virus is easily killed by the  heat and it is readily  
inactivated  by ether, acetone, ethanol 20% and  betapropionolactone. It is 
relatively resistant to ionizing radiation and UV light. 
 MORPHOLOGY 
Spherical in shape and enveloped virus 
90-120nm in size  
Genome contains two identical single strandard +one RNA copy and Reverse 
transcriptase   
Three structural genes –gag, pol and env 
 Non-structural and regulatory genes -  tat, nef, rev, vif, vpu 
                               
 
   STRUCTURE OF THE HIV VIRUS 
 
.  
 
                      
 
MAJOR ANTIGENS OF HIV 
A. Envelope  antigens  -       1.spike antigen –gp120 
                                             2.transmembrane pedicle Ag-gp41 
 
B. Shell antigen -                   Nucleocapsid protein p18  
 
C. core antigens 
                                              1.principal core antigen p24 
                                              2.other core antigens-p15,p55 
 
D. Polymembrane antigens-    p31,p51,p66 
 
GENE FUNCTION 
gag  Core of virion (incuding p24 antigen). 
pol   Protease, reverse transcriptase and integrase enzymes. 
Env Envelope glycoproteins. 
tat, rev, nef, vif, vpr, 
vpu  
Regulates viral gene replication and host cell 
modification to enhance viral growth. 
 
 
        GROUPS 
 
 4 groups - group M (major), group O (outlier),group N and group P. 
 Group M  is further subclassified into subtypes.  Includes  9 subtypes : A, 
B, C, D, F, G, H, J and K. 
 Sometimes patients are infected with more than one subtype which 
recombine to give rise to CRFs (circulating recombinant forms). 
Examples include , CRF01_AE  and  CRF02_AG. 
 Subtype A and F are further sub classified into sub – sub – types such as 
A1, A2 and F1, F2. 
 The geographic distribution of these different strains is widely 
distributed. A, B, C, D, G and CRF01-AE, CRF-AG  are by far the 
common strains globally. While subtype C is the most prevalent strain. 
 There are numerous implications to this genetic diversity such as : 
     1. Wide diversity (subtypes, circulating recombinant forms), 
 2. Continuous viral evolution, 
 3. Different rates of disease progression, 
 4. Varied response to therapy,   
    5.Development of  resistance, 
    6. Inability to develop vaccine against wide range of strains.   
GEOGRAPHIC DISTRIBUTION OF HIV &SUBTYPES 
1. Sub-Saharan Africa Subtype C (most common) 
Subtype B and G,    CRFO2_AG. 
2. India Subtype C. 
3. China Subtypes B, C and  
BC recombinant forms. 
3. Southeast Asia CRF01_AE. 
4. North America and some 
parts of South America 
Subtype B. 
5. Australia Subtype B. 
6. Western Europe Subtype B. 
7. Eastern Europe  Subtype A,B and  
AB recombinant forms. 
New emerging strains: 
Thai B.   Indian C. southern China* 
CRF03_AB  Former soviet union 
CRF14_BG  Spain*   Portugal*  
BF recombinant forms South America  
CRF35_AD  Afghanistan and Iran* 
 
 
  GEOGRAPHIC DISTRIBUTION OF HIV &SUBTYPES 
 
        
 
 
REPLICATION  CYCLE  
                     HIV virus enters into the body through blood or tissues of infected 
person. After entering the virus binds with host cell (CD4 lymphocyte) through 
using the envelope antigens  gp120  and gp41.Binding of HIV to the host cell 
can also  mediated through the HIV coreceptors CXCR4 (for Tcell trophic HIV 
strains) and CCR5(for macrophage trophic strains). 
                    After the fusion of HIV with the host cell membrane HIV genome 
is uncoated and internalised into the cell. Then  virus reverse transcriptase 
mediates the transcription of HIV RNA into double strandard DNA which is 
incorporated into the host cell genome which leads to formation of proviruses.  
 
 
                   
 
 TRANSMISSION  OF HIV        
HIV can be transmitted through sexual, blood and blood products   and 
maternal-fetal transmission. 
 
 SEXUAL TRANSMISSION 
 Can through homosexual or heterosexual route. 
 Male to female transmission rate is higher than female to male 
transmission rate .Increased risk of heterosexual transmission in  presence 
of genital ulcer. 
 
 
 
 
  Unprotected receptive anal intercourse increased the rate of           
transmission because of the thin fragile rectal mucous membrane. 
 Uncircumcised males are more prone to develop HIV infection       
because of the foreskin contains plenty of langerhan cells , CD4 T cells 
and macrophages which are the targets in AIDS 
 
TRANSMISSION BY BLOOD AND BLOOD PRODUCTS 
             The first case of HIV infection transmitted by  blood products was 
reported in 1982. HIV virus can be transmitted through transfusion of 
contaminated white blood cells, platelets and clotting factors. 
             Transfusion of hyperimmune gammaglobulin , hepatitisB Ig, HepB 
vaccine and Rh Ig will not transmit  infection. Any skin piercing including  
injection ,ear pricking, tatto and acupuncture can also transmit the infection.  
 
MOTHER TO FETUS/INFANT  TRANSMISSION 
 Maternal  to fetus transmission occurs  during pregnancy, during delivery 
and by breast feeding.  
 Low maternal CD4 count is associated with the high rate of transmission. 
 Prolonged second stage of labour also increase  risk of HIV transmission.  
                        Without  ART to the mother in the antenatal period, risk of 
mother to fetus transmission is around 10% to 25% in industrialised countries, 
20% to 25% in developing countries.With prophylactic ART, rate of 
transmission decreases by 5%. 
   Graph showing the number of perinatally acquired cases in children 
 
 
TRANSMISSION BY OTHER BODY FLUIDS 
 Saliva contains  many antiviral factors such as IgA , IgG And IGM   
mucins , thrombospondin 1, secretory lecukocyte  protease 
inhibitor(SLPI)  which inhibits the replication of HIV and increases the 
clearance by the host. 
 Exposure to body fluids such as sweat, urine and tears will not transmit 
the HIV infection. 
                      
MODES OF HIV TRANSMISSION 
 
SEXUAL ROUTE   87% 
MOTHER TO CHILD  5% 
BLOOD AND BLOOD 
PRODUCTS 
2% 
INJECTION DRUG USE 2% 
UNKNOWN 4% 
              
                    
CLINICAL FEATURES OF HIV INFECTION  
                 AIDS ( Acquired immuno deficiency syndrome) is a fatal illness 
characterised by multisystem involvement and development of various 
opportunistic infections leading to death. 
Clinical manifestation of HIV infection have been classified into 3 broad 
categories 
1. Acute HIV syndrome. 
2. Asymptomatic stage.  
3. Symptomatic disease. 
 
ACUTE HIV SYNDROME 
                    Around 50% to 70% of the individuals will develop acute HIV 
infection after 3 to 6 weeks of primary infection. Most common manifestations 
include fever, pharyngitis, headache, nausea, vomiting and diarrhoea. 
Symptoms will persist for several weeks and gradually subside. Neurology and 
dermatologic manifestations also occur in acute HIV syndrome 
 
Systemic symptoms:  
         
 
 Cutaneous manifestations 1.Mucocutaneous ulcer  
                                           2.Erythematous maculopapular rash 
Fever Pharyngitis 
Myalgia Arthralgia 
Weight loss Nausea 
Vomiting Diarrhea 
Headache Retro orbital pain 
Lymphadenopathy  
  
 
 
Neurological manifestations: 
Encephalitis Aseptic meningitis 
Acute transverse myelitis Peripheral neuropathy  
Acute demyelinating Encephalomyelitis   
 
Approximately around 10% of HIV patients will have fulminant course even 
after the disappearance of signs and symptoms. 
If antiretroviral therapy (ART) is initiated during the acute HIV infection, small 
percentage of patients may revert to a negative ELISA test. But after 
discontinuation of the treatment rapidly they will reseroconvert to positive test. 
                        
ASYMPTOMATIC STAGE 
During the asymptomatic stage antibodies to HIV is present in the serum but no 
signs and symptomps of the disease. Duration of the asymptomatic stage varies 
from months to years. During this period rate of fall of CD4 count is 
50/microlitre/year.  
 
             SYMPTOMATIC DISEASE 
During the course of illness, signs and symptoms appear at any stage of illness. 
Symptoms depends upon the rate of fall of CD4 count. As the CD4 count 
decreases, opportunistic infection increases leading to fatal complications. 
 
  
  NATURAL HISTORY OF THE DISEASE IN HIV INFECTION  
 
 
 
 DISEASES OF KIDNEY & GENITOURINARY SYSTEM 
              Diseases of genitourinary system are due to direct consequences of 
HIV infection or due to neoplasm or opportunistic infections or drug toxicities.. 
Renal biopsy is diagnostic of HIVAN.  
             Drug causing renal toxicities in HIV infection are Amphotericin, 
pentamidine, adefovir, cidofovir and foscarnet. Renal stones are caused by 
Indinavir in 10% of cases.  Condylomata lata  a form of secondary syphilis most 
common in HIV patients. 
“HIV-associated nephropathy (HIVAN), acute kidney injury (AKI), and chronic 
kidney disease (CKD) are important complications of HIV infection and may 
become  important as patients live longer duration in the era of combined 
antiretroviral therapy (ART)” 
Cross-sectional studies described a 4% to 17% prevalence of reduced kidney 
function in diverse HIV-infected populations . A recent large European cohort 
study examining CKD in HIV-infected patients found a prevalence of CKD 
around 4%. CKD and decline in renal function have been reported in 
association with older age, female gender, hepatitis B and C infections, 
diabetes, hypertension. 
 
 
NEPHROPATHY ASSOCIATED WITH HIV INFECTION 
HIVAN.  
“Classic HIVAN was a syndrome causing focal sclerosing glomerulopathy with 
severe proteinuria, renal failure, and rapid progression to ESRD. It  became the 
most common cause of ESRD in HIV-1–seropositive patients. HIVAN 
primarily occurs in patients of African descent , suggesting  a genetic 
predisposition to the disease. Duffy antigen/ receptor for chemokines has 
controversially  discussed as a candidate gene involved in the development of 
HIVAN . The estimated prevalence of HIVAN has around 3.5% in clinical 
studies to 12% in autopsy studies. Because HIVAN typically occurs late in the 
course of HIV-1 infection , risk factors for the development of HIVAN include 
a CD4 cell count 200 cells/mm3 and a high viral burden”. 
“Clinical features of this syndrome include advanced renal failure and 
proteinuria (the protein level is often—but not necessarily—at a nephrotic level 
[13 g/day]), a lack of peripheral edema despite the severe loss of protein, and, 
frequently, enlarged kidneys visible on renal ultrasound” 
 
Renal biopsy is the only means to establish the diagnosis of   HIVAN. 
Characteristic histological findings include collapsing focal and segmental 
glomerulosclerosis, tubular epithelial atrophy with microcystic dilatation of the 
tubules , and lymphocytic interstitial infiltration. Viral infection of renal cells 
seems to play an important role in the pathogenesis of HIVAN.  
RESPIRATORY SYSTEM  INVOLVEMENT         
HIV patients have six fold increase in incidence of  pneumococcal 
pneumonia. Pneumocysti carini pneumonia occurs in patients with CD4 count 
<200/microlitre. Classical chest xray finding is dense perihilar infiltrate which  
is unusual in HIV patients. 
                 Mycobacterium avium complex infection is seen in patients with 
CD4 count<50/microlitre. Fungal infections can also cause pneumoniain HIV 
patients. Two forms of Idiopathic pneumonia(Lymphoid interstitial pneumonia 
&Nonspecific interstitial pneumonia) have been recognized and are seen in 1% 
of  adult HIV patients. It occurs due to polyclonal activation of lymphocytes.  
The  disease is usually self limited. 
               Sinus infection is also common in HIV patients . Maxillary sinus is 
most commonly involved. Common organisms causing sinusitis in HIV 
infection are H.influenza and Staph aureus. Fungal infection like mucormycosis 
in HIV infection progresses very slowly and responds to amphotericinB 
DISEASE OF OROPHARYNX AND GIT 
             Gastrointestinal manifestations in HIV infections are most commonly 
due to secondary infections , Kaposi sarcomas, and lymphomas. And they occur 
in patients with CD 4 count <300 /micro litre. Most common oral infections 
include candidiasis. Oesophagitis in HIV is due to Candida, CMV, HSV 
Infections. HSV ulcers are usually multiple while CMV ulcer is usually solitary. 
Achlorhydria is also common in HIV infection but other gastric problems are 
rare. 
           Diarrheal illness in HIV is caused by bacterial infections like Salmonella, 
Shigella and Campylobacter spp, fungal infections like Penicillosis , 
Histoplasmosis, Coccididomycosis, and Parasitic infections such as 
Cryptosporidia, Microspora &Isospora belli.  
           CMV colitis was one of the common manifestations in pre ART  era, but 
after the introduction of ART its incidence have been decreased. Patients with 
gastro intestinal manifestations should be screened for ophthalmic evaluation 
for CMV retinitis. 
Few patients with HIV develop chronic gasteroenteritis.. Rectal lesions due to 
reactivation of herpes simplex are also more common in HIV infection.    
 
RHEUMATOLOGIC & IMMUNOLOGICAL DISEASES :  
              Anaphylaxis in HIV  is usually rare due to ART except Abacavir which 
can cause fatal allergic reactions. HLA B-57 strongly associated with allergic 
reactions due to abacavir.. In Sjogren’s syndrome  CD4  T cell infiltrates are 
more prominent.  
             Another type of arthritis also called as painful articular syndrome which 
involves the large joints and affects . In very few patients some rare clinical 
manifestations like leucocytoclastic vasculitis, CNS angiitis and polymyositis 
have been reported.  
 
HEPATOBILIARY MANIFESTATIONS. 
                 HCV infection is  more common  and 10 fold increase of death in 
HIV infection when compared to general population.Granulomatous hepatitis is 
one of the worst complication seen in HIV patients and the causative organisms 
are mycobacterium avium complex and fungal infections. 
            Hepatic mass also caused by tuberculosis,pertussis,hepatitis or fungal 
infections like C.immitis  and H.capsulatum may be seen  and  in HIV 
patients.Nucleoside reverse transcriptors also cause hepatitis which is fulminant 
in some patients.Indinavir can also cause hyperbilirubinemia.  Pentamidine and 
didanosine are the important causes of pancreatitis in HIV patients. 
 
DISEASES OF ENDOCRINE SYSTEM AND METABOLIC DISORDERS 
            HIV lipodystrophy is a common metabolic problem in patients 
receiving Antiretro viral therapy and develops in 30-75% of patients.  
 Characteristic features of lipodystrophy are 
 Increased total cholesterol, 
 Increased triglycerides,        
 Increased apolipoprotein B, 
 Hyperinsulinemia, 
 Hyperglycemia and 
 Fat redistribution -truncal obesity&peripheral wasting. 
             Next to lipodystrophy the other common metabolic abnormality in 
HIV patients is hyponatremia .The important causes include SIADH due to 
pulmonary and CNS lesion,due to adrenal gland involvement by HIV infection 
itself and by CMV,cryptococcosis and histoplasmosis and due to drug toxicity 
by Antiretroviral therapy. 
          Thyroid gland is most common gland involved in HIV infection and the 
most common abnormality is subclinical hypothyroidism.Grave’s disease can 
also occur 9 to 48 months after initiation of HAART. 
          Around 50% of HIV patients develops hypogonadism and erectile 
dysfunction.Testicular dysfunction can also be due to ganciclovir therapy. 
Avascular necrosis of hip and shoulder,osteoporosis have also been developed 
in HIV infection. 
DISEASE OF HEMATOPOIETIC SYSTEM  
               
    Hematolgical  abnormalities seen in HIV infection include 
anemia,leukopenia,thrombocytopenia which may be due to HIV infection, 
nutritional, drug induced, secondary infections and neoplasms.Zidovudine and 
dapsone are two drugs  most commonly associated with anemia.   
               
  In some patients generalised lymphadenopathy may be the first 
presentation.Monoclonal gammapathy of unknown significance(MGUS) have 
been reported in 3% of HIV infection. 
         
    Thrombocytopenia in HIV infection may be due to associated HCV 
infection, cirrhosis  and thrombotic thrombocytopenic purpura. Incidence of 
venous thromboembolism in HIV infection is 1% per year. Causes of bone 
marrow suppression in HIV patients include  infections like mycobacterium , 
fungus, parvovirus B19 and lymphomas and drugs like zidovudine, dapsone, 
ganciclovir , interferon alpha, trimethoprim sulfmethoxazole , pyrimethamine 
and foscarnet  
 
 OCULAR MANIFESTATIONS 
   Ocular manifestations occur in 50% of patients in late stage of HIV 
infection.Cotton wool spots are the most common fundus finding and these are 
due to retinal ischemia.CMV retinitis is one of the dangerous  ophthalmic 
complication of HIV infection and occurs in patients with CD4 count 
<100/microlitre.So all patients with  CD4 count <100/microlitre ophthalmic 
screening for CMV retinitis should be done 
                             “Acute retinal necrosis syndrome or progressive outer retinal 
necrosis is a rapidly progressing bilateral necrotizing retinitis and the patient 
may present with keratitis and iritis.It is most often associated with HSV or 
varicella infection.Syphilitic uveitis and  kaposi sarcoma of eyelids and 
conjunctiva are rarely seen in HIV infection”. 
 
 NEUROLOGICAL MANIFESTATIONS 
           Neurological problems in HIV infection is due to  direct consequence  of  
the virus or  secondary to opportunistic infections like toxoplasmosis 
,cryptococcosis,CMV infection or mycobacterial infection. 
                   Cryptococci neoformans  is the most common  cause of meningitis 
in HIV infection cccurs in patients with CD4 count less than 
100/microlitre.Diagnosis is confirmed by identification of organism in CSF  by 
Indian ink examination. 
              Behavioral problems include apathy, irritability, and lack of initiative, 
with progression to a vegetative state in some instances. Some patients develop 
a state of agitation or mild mania. These changes usually occur without 
significant changes in level of alertness. This is in contrast to the finding of 
somnolence in patients with dementia due to toxic/metabolic encephalopathies 
    
  The precise cause of HIV-associated dementia remains unclear,although 
the condition is thought to be a result of a combination of direct effects of HIV 
on the CNS and associated immune activation.           
         
 Multinucleated giant cells, macrophages, and microglial cells appear to be the 
main cell types harbouring virus in the CNS. Histologically the major changes 
are seen in the subcortical areas of the brain and include pallor and gliosis, 
multinucleated giant cell encephalitis, and vacuolar myelopathy. Less 
commonly, diffuse or focal spongiform changes occur in the white matter. 
Areas of the brain involved in motor, language, and judgment are most severely 
affected. 
        “Seizures may be initial manifestion in some patients with HIV 
infection. The seizure threshold is often lower in patients with advanced HIV 
infection due to the presence of electrolyte abnormalities” 
 
Causes of Seizures in Patients with HIV Infection 
 
 HIV encephalopathy 
 Cerebral toxoplasmosis 
 Cryptococcal meningitis 
 Primary central nervous system lymphoma 
 Progressive multifocal leukoencephalopathy 
 
 
              “Spinal cord disease is seen in 20% of patients with HIV 
infection.Three main types of spinal cord disease are vacuolar myelopathy,  
pure sensory ataxia,&paresthesia/dysesthesia. Other neurological manifestations 
present in HIV infection are progressive multifocal leukoencephalopathy, 
primary CNS lymphoma,kaposi sarcoma,aseptic meningitis, peripheral 
neuropathy(AIDP&CIDP) and myopathy”.  
 
 
IMMUNE  RECONSTITUTION INFLAMMATORY SYNDROME  
                      “ In some patients following inititation of ART , paradoxical 
worsening of preexisting , untreated or partially treated opportunistic infections 
occur due to Type 4 hypersensitive reactions. This is known as immune  
reconstitution inflammatory syndrome (IRIS). Signs and symptoms may appear 
at any time from two weeks to two years after initiation of ART and the 
symptoms include fever, localised lymphadenitis, pulmonary infiltrates, uveitis, 
sarcoidosis, grave’s disease and raised ICT. It can be fatal in few patients and 
steroids can be used in treatment of IRIS”.  
CHARACTERISTICS OF IRIS 
 Paradoxical worsening of the clinical condition following initiation of 
ART. 
 Occurs weeks to months following initiation of ART. 
 Most common in patients starting therapy with CD4 count <50/microlitre 
 Frequently seen in patients with tuberculosis. 
 Can be fatal. 
OPPORTUNISTIC  INFECTIONS IN HIV INFECTION IN RELATION  
TO CD4 COUNT 
 
                 CD4 Count < 500 / microlitre : 
 Bacterial infections like TB, Herpes simplex 
 Herpes Zoster, Vaginal Candidiasis 
 Hairy leukoplakia, Kaposi sarcoma” 
 
CD4 Count <200 / microlitre : 
 Pneumocystosis,Toxoplasmosis 
 Coccidiomycosis,Cryptosporidiosis 
  
“CD4 Count < 50 / microlitre : 
o Disseminated MAC infection, Histoplasmosis 
o CMV Retinitis, CNS Lymphoma” 
 
 
 
 
 
 
 
LABORATORY DIAGNOSIS OF HIV INFECTION 
                                  “Diagnosis of  HIV infection based on demonstration of 
antibodies to virus or direct demonstration of HIV or one of its components 
.Antibodies to HIV in the blood appears generally 3-12 weeks of infection” . 
 
ELISA(ENZYME LINKED IMMUNOSORBENT ASSAY) TEST  
                 It is the best screening test for HIV infection. This test is also known 
as enzyme immunoassay. Results of this test is graded as positive(highly 
reactive), intermediate (partially reactive) and negative (nonreactive). 
                   If results are intermediate it should be repeated within 4-6 wks 
ELISA test is positive usually within 22 days of infection. 
 
 
 
WESTERN BLOT TEST 
                Western blot based on detection of specific antibody to viral core 
protein p24 and envelope glycoprotein p41. Results of this test is also graded as 
positive(highly reactive),intermediate (partially reactive) and negative 
(nonreactive). If results are intermediate it should be repeated within 4-6 weeks 
 
 
WESTERN BLOT TEST 
 
 
  TESTS FOR MONITORING OF PATIENTS WITH HIV INFECTION 
1.CD4  T cell count  
2.HIV RNA estimation  
3.Complete blood count  
4.HIV resistance testing  
5.Co-receptor tropism arrays. 
6.Beta2 microglobulin                                      
   INITIAL EVALUATION OF PATIENT WITH HIV INFECTION  
 History&Physical examination  
  Complete hemogram 
 Liver and renal function tests 
 Blood sugar&Lipid profile 
 CD4 count  
 HIV RNA level 
 Screening for Hepatitis A,B&C,syphilis&tuberculosis 
 Pretest counseling 
 
INDICATIONS FOR INITIATION FOR ANTIRETROVIRAL  
THERAPY        
  1.Acute infection syndrome 
  2. Chronic infection 
A. Symptomatic disease (including HIV-associated         
    nephropathy) 
B. Asymptomatic disease 1. CD4+ T cell count <500/  
                                          2. Pregnancy 
  3. Postexposure prophylaxis. 
 
POSTEXPOSURE PROPHYLAXIS  
                Postexposure prophylaxis is a necessary secondary preventive 
measure in health care workers and and those who are exposed to risk of HIV 
infection. Post exposure prophylaxis should be initiated as soon as possible 
within the first few hours and not later than 72hours of exposure.Two NRTI’S 
used for 4 weeks for less severe exposure and two NRTI’S plus other group of 
drugs.  
MONITORING THE EFFICACY OF ART : 
 “Clinical improvement – gain in weight, decrease in occurrence  & 
severity of HIV related infections 
 Increase in total lymphocyte count  
 Improvement in biological markers of HIV – CD4 count & RNA” 
PREVENTIVE MEASURES IN HIV INFECTION : 
                 Health Education regarding safe sex practice,avoidance of IV drug 
abuse and tattooing is most important measure in preventing HIV 
transmission.All blood donors should be screened for HIV infection to prevent 
blood borne infections. 
                  Avoiding unnecessary injections and use of sterilised  disposable 
needle & syringes are also an effective measures in preventing HIV 
transmission. 
               Pregnant women with HIV infection should be advised to avoid 
pregnancy to reduce the mother to fetus transmission.  
                  
    CLASSIFICATION OF ANTI RETROVIRAL DRUGS 
NUCLEOSIDE OR NUCLEOTIDE REVERSE TRANSCRIPTASE 
INHIBITORS 
DRUGS DOSE COMMON SIDE EFFECTS 
ZIDOVUDINE 200mg tds or 
300 mg bd 
Anaemia, neutropenia, lactic 
acidosis, cardio toxicity 
DIDANOSINE 200mg bd Peripheral neuropathy, pancreatitis, 
hepatitis. 
ZALCITABINE 0.75mg tds Peripheral neuropathy, aphthous 
ulcers, hepatitis. 
STAVUDINE 40mg bd Peripheral neuropathy, pancreatitis, 
hepatitis. 
LAMIVUDINE 150mg bd Rash and peripheral neuropathy 
EMTRICITABINE 200 qid Skin discoloration and hepato 
toxicity. 
ABACAVIR 300 bd Rash, fever. 
TENOFOVIR 300 qid Gastrointestinal distress. Renal 
toxicity. 
 
 
NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS 
DRUGS DOSE COMMON SIDE EFFECTS 
NEVIRAPINE 200mg  
od 
Skin rash, hepatotoxicity. 
DELAVIRIDINE 400 mg 
tds 
Skin rash, hepatotoxicity 
EFAVIRENZ 600 mg Skin rash, neurological disturbances 
od 
EDRAVIRINE 200 mg 
bd 
Skin rash. 
RILIPIVIRINE 25 mg 
qid 
 Dizzinesss,nausea,vomiting, neurological 
disturbances 
 
PROTEASE INHIBITORS 
DRUGS DOSE COMMON SIDE EFFECTS 
SAQUINAVIR 1000mg bd GI disturbances, dyslipidemia, PR and QT 
interval prolongation 
RITONAVIR 600 mg bd GI disturbances, dyslipidemia, hepatitis 
INDINAVIR 800 mg tds Dyslipidemia, renal stones. 
NELFINAVIR 750 mg tds GI disturbances, dyslipidemia, 
AMBRANAVIR 1200 mg bd GI disturbances, dyslipidemia, renal stones. 
LOPINAVIR 400mg 
/100mg bd 
GI disturbances, dyslipidemia, PR and QT 
interval prolongation 
ATAZANAVIR 400 mg qid GI disturbances, dyslipidemia, PR and QT 
interval prolongation, skin rash. 
TIPRANAVIR 500 mg bd GI disturbances, dyslipidemia, skin rash, 
hepatitis, intracranial hemorrhage 
DARUNAVIR 600 mg bd GI disturbances, dyslipidemia, skin rash, 
hepatitis. 
ENTRY INHIBITORS 
DRUGS DOSE COMMON SIDE EFFECTS 
ENFUVIRTIDE 90 mg sc 
bd 
Skin rash, local injection reaction, bacterial 
pneumonia 
MARAVIROC 150 to 600 
mg bd 
Hepatotoxicity, skin rash,  gastro intestinal 
disturbances, musculoskeletal symptoms. 
INTEGRASE INHIBITORS 
DRUGS DOSE COMMON SIDE EFFECTS 
RALTEGAVIR 400mg bd GI disturbances, muscle weakness, 
rhabdomyolysis. 
ELVITEGRAVIR Under 
trial 
Under trial. 
 
RENAL ABNORMALITIES IN HIV PATIENTS 
“HIV infection is the one of the leading cause of acquired renal disease throught 
the world. Renal abnormalities are one of the most common cause of death in 
HIV patients.HIV -1 infection is associated with glomerular and tubule 
interstitial  disease, and patients with HIV infection are likely to risk for nephro 
toxicity from antiretroviral therapy as well as from other medications. Co 
infections with the other pathogens, in particular hepatitis B and hepatitis C 
viruses, can complicate the clinical picture. Acute kidney injury and interstitial 
nephritis, due to medications and opportunistic infection, are not uncommon. As 
patients with HIV infection live longer period with ART, patients experiencing   
the  complex, interacting  effects of HIV itself, ART and  the worldwide 
diseases of development, including atherosclerosis, metabolic syndrome, type 2 
diabetes and end stage renal disease are  most common renal complications in 
HIV patients include asymptomatic micro albuminuria, Acute kidney injury, 
Glomerulardiseases,vascularnephropathy,tubulointerstitialnephritis,fluid and 
electrolyte abnormalities and chronic kidney disease”. 
 
ACUTE RENAL FAILURE 
Acute renal failure has been reported in 20% of hospitalized HIV patients. The 
most common causes include prerenal  azotaemia or acute tubular necrosis due 
to infection, diarrheal diseases, septicaemia ,bleeding, hypoalbuminaemia or 
nephrotoxins. Other least common causes include tubulo interstitial nephritis 
and crystal nephropathy. The main pathogenesis of prerenal azotaemia is due to 
true or effective depletion of intravascular volume. True volume depletion is 
mainly because of gastrointestinal fluid loss associated with diarrhea and / or 
vomiting. These patients are likely prone for disordered renal regulation of salt 
and water balance leading onto further intravascular volume depletion. 
Insensible fluid losses associated with pulmonary disorders i.e lung fluid loss 
due to pneumonia and prolonged fever also results in decreasing intravascular 
volume. sepsis due to bacterial and fungal organisms is the leading cause of 
haemodynamic ARF in HIV patients. The main mechanism of prerenal 
azotaemia in sepsis is due to combination of endotoxin associated systemic 
vasodilatation , arterial hypotension, capillary leakage, and renal arteriolar  
vasoconstriction  associated with vasopressor drug therapy. Other causes of 
prerenala zotaemia in HIV patients include hepatorenal syndrome severe 
pancreatitis caused by various infections and drugs, and congestive 
cardiomyopathy. Medication induced ATN is the most common cause of ARF 
in hospitalized HIV patients. Because of  their attenuated volume depleted state, 
these pateints are at higher risk of drug induced ATN. Pentamidine and 
Amphotericin B are the other drugs which can cause ATN in HIV patients. 
Amphotericin B infusion acutely decreases renal blood flow and induces 
ischemic injury by the way of afferent arteriolar vasoconstriction. It also 
directly disrupts renal tubular membranes in a dose dependent manner.   
 
ACUTE TUBULOINTERSTITIAL NEPHRITIS 
ATIN classically presents with triad of fever, rash and eosinophilia. The 
development of this classical triad is extremely variable and more often due to 
both the class of drugs and the host response to the offending medication. Urine 
analysis helps in the diagnosis of ATIN by showing low grade proteinuria, renal 
tubular cells, erythrocytes, and leukocytes and cast. Eosinophiluria, which is 
sometimes present in patients with ATIN, but it is not specific for the disease. 
Gallium scanning is also useful to provide more information in the evaluation of 
suspected ATIN. Gallium uptake persists for 48 to 72 hours, but it is not 
specific for the diagnosis of ATIN, but appears relatively sensitive. Gold 
standard diagnosis for ATIN is renal biopsy. Biopsy specimen shows either 
patchy or diffuse infiltration of the interstitium with lymphocytes, plasma cells 
and eosinophils. Medications causing ATIN in HIV infected patients 
1.beta-lactam antibiotics 
2.sulfonamides 
3.Histamine receptor blockers 
4.quinolones 
5.allopurinol 
6.phenytoin 
7.NSAID 
 
 
CRYSTAL INDUCED NEPHROPATHY 
 
“Deposition of insoluble crystals at kidney results in nephropathy in HIV 
infected patients. Intratubular crystal precipitation causes severe ARF. 
spontaneous chemotheraphy induced lysis of tumour cells is associated with 
release of intracellular purines that are converted to uric acid in systemic 
circulation. These crystals are precipated in  tubular lumen of the distal nephron 
causing intrarenal obstruction. Intravascular depletion and also acidic urine 
increases the risk of crystal deposition. Medications like sulphadiazine, 
acyclovir, indinavir and foscarnet causes intrarenal crystal deposition. Acidic 
urine causes further increases precipitation of these drugs in the kidney. 
Hypoalbuminaemia also results in higher plasma and urine free concentration of 
sulphonamides. Urine analysis results in characteristic needle shaped or rosette 
formation. Renal ultrasound studies reveal sulpha based uroliths and other 
calculous material sludging in the renal calices”. 
 
“ETIOLOGY OF HIV ASSOCIATED CRYSTAL NEPHROPATHY 
CRYSTAL TYPE RISK FACTORS 
Uric acid Volume depletion 
Acid urine (pH <5.5 
Sulfadiazine Volume depletion 
Acid urine (pH <5.5) 
Renal insufficiency 
Acyclovir Volume depletion 
Renal insufficiency 
Rapid intravenous infusion 
Indinavir Volume depletion 
Alkaline urine (pH>5) 
Foscarnet  Volume depletion 
Renal insufficiency 
Rapid intravenous infusion” 
 
 
GLOMERULAR DISORDERS 
 
Glomerular disorder of HIV infection is a collapsing glomerulopathy. 
Previously it was explained as focal segmental glomerulosclerosis and then it is 
called as HIV associated glomerulopathy. HIV associated glomerulopathy 
explains all the pathological process in glomeruli associated with HIV infection. 
 
 
ETIOLOGY AND PATHOGENESIS 
HIV associated Collapsing glomerulopathy occurs in acute and chronic 
infection. In chronic cases, there will be high Viral RNA level with low CD4 t-
lymphocyte count. In chronic and latent infection glomerular and tubular cells 
are affected. Accessory HIV proteins damage the renal cells, it was 
experimentally done in transgenic mouse. It seems to that variation in MYH9 
risk haplotype contributes to the risk for focal segmental glomerulosclerosis and 
collapsing glomerulopathy. MYH9 genetic variation is associated with 
Apolipoprotein L1, which is a constituent of HDL 
 
 
CLINICAL MANIFESTATIONS 
Edema, Proteinuria and Renal insufficiency,  Reduced GFR. Imaging 
studies proved the increased kidney size. Increased echogenicity, but this is an 
unusual feature correlated with diabetic nephropathy and amyloid nephropathy. 
Renal biopsy is needed to confirm the disease. 
PATHOLOGY 
“On histological examination, HIV associated collapsing glomerulopathy 
is indistinguishable from Idiopathic collapsing glomerulopathy and is a pan-
nephropathy with pathologic changes in glomeruli, tubules and interstitium. 
Both condition manifest tubuloreticular inclusions within dilated endosomal 
compartments within dilated endosomal compartments within glomerular 
endothelial cells, that is the marker for cytokine injury. In patients with 
hypertensive nephrosclerosis or interstitial nephritis, there will be 
glomerulomegaly and post adaptive FSGS caused by the glomerular 
hyperperfusion and hyperfiltration”. 
 
DIAGNOSIS AND DIFFERENTIAL DIAGNOSIS  
 
“Renal biopsy shows the classical changes of HIV associated collapsing 
glomerulopathy. Low CD4 count and Nephrotic proteinuria indicates HIV 
associated collapsing glomerulopathy. Plasma HIV RNA of less than 
400copies/ml  indicates another disease is more likely. Other diagnosis include 
the  Diabetic nephropathy, hypertensive nephrosclerosis, HIV related immune 
complex glomerulonephritis”. 
 
HIV ASSOCIATED IMMUNE COMPLEX GLOMERULONEPHRITIS 
“In European and asian descends the common glomerular pathology 
associated with HIV is Immune complex glomerulonephritis (ICGN). It is also 
seen in African descends. Major pathogenesis is not clear but it is believed that 
the disease is due to HIV antigen, but in some cases the immune complex 
shown to include HIV antigen and some are due to the general polyclonal B cell 
expansion that accompanies HIV disease. The patients present with hematuria 
and proteinuria thus it is clinically indistinguishable from HIV associated 
collapsing glomerulopathy. Histologically glomeruli shows diffuse or focal 
proliferative glomerulonephritis with endocapillaryproliferation.immune 
deposits are characterized by IgG and IgM or byIgG,IgM and IgA often with 
C3. They are similar to lupus nephritis but the serology for lupus is negative. 
The long term outcome of HIV associated ICGN has not been well defined but 
in general it is believed to be relatively benign in most of the cases, there are 
few studies of therapy, presumably, control of HIV infection and conservative 
measures to control blood pressure and proteinuria are indicated”. 
 
ELECTROLYTE DISTURBANSES  IN HIV INFECTED PATIENTS: 
 
SODIUM BALANCE : 
Sodium is actively pumped out of cells by the Na,K+ -ATPase pump. 
Sodium around 85%- 90% is extracellular and ECF volume is a reflection of 
total body sodium content. Normally there is always balance occurs between 
sodium loss and sodium gain, If it fails edema and hypovolemic state occurs due 
to sodium excess and sodium deficit.Change in Na concentration usually reflect 
disturbed water haemostasis. 
 
HYPONATREMIA 
    Hyponatremia is a common finding among HIV-infected persons, with a 
reported prevalence of 30-60% in hospitilized patients. It  is associated with 
increased mortality in HIV-infected patients. In a study of 96 consecutive 
patients with acquired immune deficiency syndrome (AIDS) or AIDS-related 
complex(ARC) conducted in department of medicine, long island Jewish 
medical centre, New Hyde Park 11042,31.3% patients had hyponatremia. The 
probability of 50% survival after diagnosis of HIV infection in the 
hyponatremic group was 11.5 months as compared to 39 months for those 
without hyponatremia, p less than0.001. 
 
The etiology and treatment of hyponatremia may differ according to the 
timing of its presentation. Volume depletion caused by diarrhoea or vomiting is 
the usual cause of hyponatremia present at the time of hospital admission. The 
management includes correction of the volume depletion and also the treatment 
of the underlying. In contrast, the syndrome of inappropriate antidiuretic 
hormone(SIADH) is the likely culprit among patient who develop hyponatremia 
during hospitalization .SIADH is associated with common pulmonary and 
intracranial diseases such as pneumocystis jiroveci pneumonia, toxoplosmosis 
and tuberculosis. 
 
POTASSIUM BALANCE: 
It is major intracellular cation. Normal serum K+ level is 3.5-5.0 
mmol/L,but intracellular level is 150 mmol/L so ECF contain <2 % of total 
body potassium level. The ratio of ICF to ECF K+ level is 38:1.This is 
responsible for the development of resting membrane potential and essential for 
neuromuscular function. 
 
 
HYPOKALEMIA: 
It is defined as plasma K+ level less than 3.5 mmol/L. Hypokalemia 
causes intracellular acidification , which result in increased acid excretion and 
new HCO3- production. It occurs due to increased HCO3- reabsorption in PCT 
& increased H
+   
secretion distally. This is the reason for occurrence of 
metabolic alkalosis in patients with hypokalemia 
Clinical findings: 
    Presents with fatigue,muscle cramps in mild cases. Constipation, ileus , 
flaccid paralysis , tetany, hypercapnea , hyporeflexia and  rhabdomyolysis seen 
in severe hypokalemia. 
 
HYPERKALEMIA : 
Plasma K
+
 level more than 5.0 mmol/L.It is due to either potassium 
release from cells or decreased renal loss. Clinical features depends upon the 
ratio of ICF to ECF K
+
 concentration. Both hyperkalemia and hypokalemia are 
common among HIV infected patients, Hypokalemia   occurs due to vomiting 
and diarrhoea after  GI infection. Amphotericin causes tubular dysfunction 
causing  diarrhoea. Drug induced hyperkalemia occurs in patients receiving 
either high dose trimethoprim-sulfamethoxazole or iv pentamidine. Kidney 
disease in HIV patients either acute or chronic   may contribute to potassium 
retention. Other  electrolyte disturbances were hypocalcemia, hypercalcemia, 
hypouricemia, hyperuricemia, lactic acidosis and  hypophospotemia. 
                      MATERIALS AND METHODS 
 
STUDY POPULATION: This study was conducted among 200 HIV 
positive patients coming to ART centre, Govt.Rajaji Hospital, Madurai 
during the period of  February  2016 to July 2016. The study group will be 
divided into two groups: Group A ART naive patients and Group B HIV 
patients on ART 
INCLUSION CRITERIA: 
All patients aged greater than 18 attending  ART OPD, diagnosed with HIV 
infection irrespective of Anti Retroviral Therapy 
EXCLUSION CRITERIA:   
 Patient with Diabetes mellitus 
Endocrine disorder 
Known Chronic kidney disease    
Obstructive uropathy 
Pregnancy 
                                              
ANTICIPATED OUTCOME: High prevalence of Renal and Electrolyte 
disturbances in HIV infected patients.  
DATA COLLECTION:  
                    A previously designed proforma will be used to collect the 
demographic and clinical details of the patients. Two hundred patients will 
be selected randomly. All the patients will undergo detailed clinical 
evaluation, appropriate  investigations. History will be taken on details of 
unprotected sexual intercourse , blood transfusion, IV drug abuse, repeated 
respiratory infections, fever , recurrent diarrhoea and unexplained weight 
loss. Presence of lymphadenopathy, oral ulcers, splenomegaly and peripheral 
neuropathy will be noted. Blood urea, serum creatinine, blood glucose, 
Serum electrolytes , CD4 count, urine routine and 24 hour urine protein will 
be estimated..The study group will be divided into two groups: Group A 
ART naive patients and Group B HIV patients on ART. 
LABORATORY INVESTIGATIONS:  “CD4+ count, Blood sugar, Blood 
Urea, Serum Creatinine, Serum sodium, Serum potassium, serum chloride, 
urine routine and 24 hour urine protein”. 
 
DESIGN OF STUDY:  cross sectional study 
PERIOD OF STUDY: February 2016 To July 2016 ( 6 months) 
COLLABORATING DEPARTMENTS: 
 Department Of Biochemistry   
 ART CENTRE 
 
ETHICAL CLEARANCE: Applied for 
CONSENT: Individual written and informed consent. 
ANALYSIS:STATISTICAL ANALYSIS. 
CONFLICT OF INTEREST: NIL 
FINANCIAL SUPPORT:  SELF 
PARTICIPANTS: All patients with HIV infection, attending ART OPD  of 
Government Rajaji Hospital, Madurai from February 2016 to July 2016  will 
be included in this study 
OBSERVATION AND RESULTS 
            Table 1   Age distribution of the study population (n=200) 
Age 
No Of 
Patients 
<20 6 
21-40 121 
41-60 72 
>60 1 
Total 200 
Mean 37.075 
SD 10.71 
 
Comments: “About 60% of study population were in the age group of 21-40 
years and 36% of study populalation  were in the age group of 41-60 years’  
 
Comment: Most of study population  were in the age group of 21 to 60years. 
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  SEX DISTRUBUTION 
 
Sex 
No Of 
Patients 
Male 131 
Female 69 
Total 200 
 
 
 
Comments: Males are slightly higher than in the study population  
     
131, 
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69, 
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SEX DISTRIBUTION 
Male 
 CD4 COUNT DISTRIBUTION 
CD4 COUNT 
No Of 
Patients 
<200 34 
201-500 89 
501-1000 64 
>1000 13 
Total 200 
Mean 480.89 
SD 319.871 
 
 
                      
   Comments :  Around 45% patients have CD4 count between 200-500 and 
32% patients have CD4 count 501-1000.            
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ART DISTRIBUTION 
  No Of Patients 
ART    76 
ART NAÏVE 124 
Total 200 
 
 
 
 
Comments  -38% were on ART , 62% were  ART naive. 
Male Female Total
ART 45 31 76
Nil 86 38 124
Total 131 69 200
76, 38% 
124, 62% 
ART DISTRIBUTION 
ART    
UREA DISTRIBUTION 
UREA No Of Patients Mean 
<40 167 24.21 
> 40    33 62.66 
Total 200   
Mean 30.140   
SD 15.372   
 
 Mean urea level in the study population was found to be 30.140 ; with a 
standard deviation of 15.372 
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  UREA 
 ART STATUS Mean SD 
ON ART 27.26 12.659 
ART NAIVE 31.90 16.623 
P VALUE 0.038 Sig   
 
 
Comments: 
Elevated urea   levels were found in 16.5% of study population. Among 
them elevated urea more in ART NAÏVE patients than patients taking ART.  
.p value of  <0.038  statistically  significant; indicates ‘renal abnormalities 
are higher in ART NAÏVE patients than patients on ART’. 
 
  
 
 
 
CREATININE DISTRIBUTION 
CREATININE No Of Patients Mean 
 < 1.3 167 0.92 
> 1.3   33 2.22 
Total 200   
Mean 1.109   
SD 0.618   
 
 
 
Comments : 
Around 33 (16.5 ) patients were found to be having elevated serum 
creatinine >1.3 . Mean serum creatinine in the study population is 1.109 with 
a standard deviation of 0.618. 
  
 
CREATININE 
ART STATUS Mean SD 
ON ART 1.00 0.328 
ART NAIVE 1.18 0.735 
P VALUE 0.047  sig   
 
Comments : 
                    Mean creatinine in patients taking ART was 1.00 . Mean 
creatinine in ART naive patients was 1.18. p value 0.047 statistically 
significant; indicates renal abnormalities are higher in ART NAÏVE patients 
than patients on ART’. 
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  SODIUM DISTRUBUTION:                  
Na+ No Of Patients Mean 
<135 72 126.9 
135-145 127 138.8 
>145 1 147 
Total 200   
Mean 133.7   
SD 7.199   
 
Comments: Around 72 (36% ) patients were found to be having 
hyponatremia . Mean serum sodium  in the study population is 133.7 with a 
standard deviation of 7.199 
  ART +  (27) ART - (45) 
  Male Female Male Female 
Hyponatremia (72) 17 10 27 18 
 
Comments :  Among them 27 patients(37.5% )on ART  and 45 
patients(62.5%) were ART NAÏVE.. 
  
 
 
Comments :  
                              Among them 27 patients (37.5% )on ART  and 45 
patients(62.5%) were ART NAÏVE. 
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ART +  (27) ART - (45) 
Hyponatremia (72) 
   Na + 
 ART STATUS Mean SD 
ON ART 135.13 6.109 
ART NAIVE 132.82 7.685 
P VALUE 0.027  sig   
 
Comments: 
                      Serum sodium level found to be   decreased in more  ART 
naïve patients than those on ART, p value was< 0.027, statistically 
significant ,indicate Na+ level was significantly lower in ART NAÏVE 
patients compared to patients on ART. 
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DISTRUBUTION OF POTASSIUM 
K+ No Of Patients Mean 
< 3.5 41 3.06 
3.51 - 5.0 140 4.09 
>5.0 19 5.55 
Total 200   
Mean 3.892   
SD 0.894   
    
 
Comments :   
Around 41 (20.5% ) patients were found to be having hypokalemia . Mean 
serum potassium  in the study population is 3.892 with a standard deviation of 
0.894 
     
  
Comments : 
                       Serum Potassium level  decreased in 41 patients(20.5%) of study 
population, among them 13 patients (31.7% ) on ART  and 28 patients(68.3%) 
were ART NAÏVE.  
  ART +  (13) ART - (28) 
  Male Female Male Female 
Hypokalemia (41) 6 7 17 11 
 
Comments :                    Serum Potassium level  decreased in 41 
patients(20.5%) of study population, among them 13 patients (31.7% ) on ART  
and 28 patients(68.3%) were ART NAÏVE.  
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 Comments : Serum Potassium level  decreased in 41 patients(20.5%) of study 
population, among them 13 patients (31.7% ) on ART  and 28 patients(68.3%) 
were ART NAÏVE.  
  ART +  (13) ART - (6) 
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Comments : Serum Potassium level  increased in 19 patients(9.5%) of study 
population, among them 13 patients(68.4% )on ART  and 6 patients(31.6%) 
were ART NAÏVE.  
 
 
Comments : 
Serum Potassium level  incresed in 19 patients(9.5%) of study population, 
among them 13 patients(68.4% )on ART  and 6 patients(31.6%) were ART 
NAÏVE. Serum Potassium level found to be  increased in more  ART  patients 
than those on ART NAÏVE. 
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3 
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Male Female Male Female 
ART +  (6) ART - (13) 
Hyperkalemia (19) 
  
  K + 
 ART STATUS Mean SD 
ON ART 4.09 0.844 
ART NAIVE 3.77 0.906 
P VALUE 0.015  sig   
      
Comments: Serum Potassium level found to be  decreased in more  ART naïve 
patients than those on ART, p value was< 0.015, statistically significant 
,indicate K+  level was significantly lower in ART NAÏVE patients compared to 
patients on ART. 
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ART + 
URINE PROTEIN No Of Patients 
++ 37 
NIL 163 
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  ART +  (9) ART - (24) 
  Male Female Male Female 
Protenuria (33) 6 3 18 6 
 
 
Comments :                        Proteinuria  present  in 33 patients (16.5%) of study 
population, among them 9 patients (27% ) on ART  and 24 patients (73%) were 
ART NAÏVE. Significant proteinuria was higher in  ART NAÏVE patiens and 
lower in patient taking ART.  
33, 18% 
167, 82% 
URINE PROTEIN 
++ 
USG Renal cortical echoes : 
USG- ↑ renal cortical echoes  No Of Patients 
+ 30 
NIL 170 
Total 200 
 
 
 
Comments : 
                                    USG abdomen shows increased cortical echoes in  30 
patients (15%) of study population, among them 7 patients (23% ) on ART  and 
23 patients (77%) were ART NAÏVE. Renal cortical echoes were higher in  
ART NAÏVE patiens and low occurence in patient taking ART.  
30, 15% 
170, 
85% 
USG RENAL CORTICAL ECHOES 
+ 
 CD4 CORRELATION COEFFICIENT; 
  
CORRELATION 
coefficient   
CD4 COUNT VS UREA 0.04 Very Low 
CD4 COUNT VS 
CREATININE -0.01 Neg 
CD4 COUNT VS Na+ 0.128 Low 
CD4 COUNT VS k+ 0.071 Very Low 
    
 
Comments :  
                                    In this study, there is very low correlation coefficient 
between  CD4 counts and urea. There is negative correlation coefficient 
between CD4 counts and creatinine. The correlation coefficient is low 
between CD4 count and Na
+
 ,K
+
 levels. 
 
 
 
  
DISCUSSION  
                Renal and electrolyte abnormalities are more common in HIV 
infection .This study was conducted in 200 HIV patients selected randomly 
irrespective of their ART status who attending ART clinic, Government Rajaji 
Hospital, Madurai. The study population were divided into 2 groups according 
to ART status. Group A ART naive patients and Group B HIV patients on ART. 
.About 60% of study population were in the age group of 21-40 years and 36% 
of study population  were in the age group of 41-60 years. 
                
 Around 62% of study population were ART NAIVE and 38% were on ART. 
Gender distribution is of around 65%  male  and 35% female. Blood  urea 
,serum creatinine, Urine protein ,Serum sodium. Serum potassium and USG 
abdomen were performed in study populations. 
 
Blood urea level was raised in 33 patients (16.5%) of study population, among 
them 9 patients (27% )on ART  and 24 patients (73%) were ART NAÏVE. 
Blood urea level raised in ART naïve patients, p value was 0.038, statistically 
significant , indicate urea level was higher in ART NAÏVE patients and lower  
in patient taking ART. 
Serum creatinine level was raised in 33 patients (16.5%) of study population, 
among them 9 patients (27% ) on ART  and 24 patients (73%) were ART 
NAÏVE. Serum creatinine level raised in ART naïve patients, p value was 
0.047, statistically significant, indicate cretinine level was higher in ART 
NAÏVE patients and lower  in patient taking ART.  
 
Proteinuria  present  in 33 patients (16.5%) of study population, among them 9 
patients (27% ) on ART  and 24 patients (73%) were ART NAÏVE. Significant 
proteinuria was higher in  ART NAÏVE patiens and lower in patient taking 
ART.  
USG abdomen shows increased cortical echoes in  30 patients (15%) of study 
population, among them 7 patients (23% ) on ART  and 23 patients (77%) were 
ART NAÏVE. For all the patients, cortico medullary differentiation was 
maintained. Renal cortical echoes were higher in  ART NAÏVE patiens and low 
occurence in patient taking ART.  
Review literature shows that Renal involvement found to be common in HIV 
infected patients.A low occurrence of renal involvement found in patients 
taking ART’.HIV nephropathy in US population shows heavy proteinuria and 
they found to develop progressive renal disease. So HIV patients are to be 
monitored for proteinuria. It helps to know about 1)Triggering factor 
2)Progression of renal involvement 3)To minimize renal complication. HIV 
infected patients with oppurtinstic infectios were more prone for renal and 
electrolyte disturbances. 
Review literature shows renal complications affects particular group of people  
that there will be a host response or genetic component linked with the disease 
incidence. The genetic predisposition in the pathogenesis of HIV nephropathy 
were cytokines    such as  
1)TGF – B    
 2)IL – 8  
 3)Monocytic chemotactic protein 1  
 4)RANTES  
 5)IFN. The above cytokines levels were found to be elevated in HIV patients 
with nephropathy. Over all study shows there is increased renal disturbances in 
ART NAÏVE patients than patients on ART suggest some renoprotective effect 
of ART and indicates decreased incidence of oppurtinistic infections. 
 
Serum sodium level  decresed in 72 patients(36%) of study population, among 
them 27 patients(37.5% )on ART  and 45 patients(62.5%) were ART NAÏVE. 
Serum sodium level found to be  decreased in more  ART naïve patients than 
those on ART, p value was< 0.027, statistically significant ,indicate Na+ level 
was significantly lower in ART NAÏVE patients compared to patients on ART.  
 
Serum Potassium level  decresed in 41 patients(20.5%) of study population, 
among them 13 patients(31.7% )on ART  and 28 patients(68.3%) were ART 
NAÏVE. Serum Potassium level found to be  decreased in more  ART naïve 
patients than those on ART, p value was< 0.015, statistically significant 
,indicate K+  level was significantly lower in ART NAÏVE patients compared to 
patients on ART 
 
Serum Potassium level  increased in 19 patients(9.5%) of study population, 
among them 13 patients(68.4% ) on ART  and 6 patients (31.6%) were ART 
NAÏVE. Serum Potassium level found to be  increased in more  ART  patients 
than those on ART NAIVE, Probably due to drug intake such as Co-
Trimoxazole, etc,. 
Hyponatremia, hypokalemia and hyperkalemia are common electrolyte 
disturbances in HIV. I described here higher incidence of electrolyte 
disturbances in ART naive patients  than patients taking ART. Numerous 
factors contributing this. Among 200 patients 72 patients had hyponatremia.The 
percentage of hyponatremia is 36%. 
The incidence of hyponatremia may be due to 
1.Volume depletion due to diarrhea and vomiting 
2.The syndrome of inappropriate antidiuretic hormone 
3.Persistent release of antidiuretic hormone release from infections. 
In persistent vomiting and diarrhea cause hypoosmolar hyponatremia , but in 
SIADH there is euvolemic. 
Hypokalemia occur due to gastrointestinal infections causing vomiting and 
diarrhea. “ Tenofovir has associated with proximal tubular dysfunction results 
in salt wasting state, including life threatening hypokalemia”. 
 
 
 
 
 
 
 
 
SUMMARY: 
                 HIV infection is most commonly  associated with renal and 
electrolyte  abnormalities. This study was conducted in 200 HIV patients 
irrespective of their ART status, and the study population were divided into 2  
groups. Group A ART NAIVE patients and Group B patients taking ART. 
About 60% of study population were in the age group of 21-40 years and 36% 
of study population  were in the age group of 41-60 year. 
 
Around 62% of study population were ART NAÏVE remaining 38% of study 
population were taking ART. In the study group, 65% were males and 35% 
were females. Blood urea, Serum creatinine, Serum sodium , Serum Potassium
,
 
Urine protein and USG abdomen were done in all patients. 
 
Elevated urea  and  creatinine levels were found in 16.5% of study population. 
Among them elevated renal parameters more in ART NAÏVE patients than 
patients taking ART. Since  means are compared student t test used in this 
study. p value <0.038 and < 0.047 statistically  significant indicates renal 
abnormalities are higher in ART NAÏVE patients than patients on ART. 
Proteinuria  present  in 15% of the study population, which is more among ART 
NAÏVE patients. USG abdomen study shows increased renal cortical echoes  in 
15% of the study population. Cortico  medullary differentiation maintained in 
all patients. It excludes chronic kidney disease.  
 
Hyponatremia  found in 36% of study population. Among them hyponatremia 
more in ART NAÏVE patients than patients taking ART. ‘p value <0.027  
statistically  significant indicates hyponatremia are higher in ART NAÏVE 
patients than patients on ART’ 
 
Hypokalemia  found in 20.5% of study population. Among them hypokalemia 
more in ART NAÏVE patients than patients taking ART. ‘p value <0.015  
statistically  significant indicates hypokalemia are higher in ART NAÏVE 
patients than patients on ART’. 
 
Hyperkalemia  found in 9.5% of study population. Among  them  hyperkalemia 
less in ART NAÏVE patients than patients taking ART. In this study, there is 
very low correlation coefficient between CD4 counts and urea. There is 
negative correlation coefficient between CD4 counts and creatinine. The 
correlation coefficient is low between CD4 count and Na
+
 ,K
+
 levels 
 
 
 
 
 CONCLUSION : 
 Renal involvement was seems to be common in Indian patients with HIV.  
Elevated Blood urea, serum  creatinine  and  proteinuria  could be an 
early marker of HIV associated renal lesions and screening for their 
presence may be beneficial. 
 A low occurrence of renal involvement found in patients already on ART 
suggests some renoprotective effect of ART 
 Hyponatremia, hypokalemia and hyperkalemia are common electrolyte 
disorders in HIV infected patients. Among them hyponatremia and 
hypokalemia incidence more in  ART NAIVE patients than patient on 
ART. 
 This  indicates   decreased  incidence of electrolyte disturbances on 
patients on ART may be  due to less oppurtunistic infections in them. 
 The present findings need to be confirmed with  further studies with 
larger sample size and prolonged period of follow up. 
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                                           PROFORMA 
 
Name: 
Age / Sex: 
IP / OP no: 
Occupation: 
Presenting complaints: 
 
 
Past History: 
H/o , unprotected sexual intercourse, blood transfusion, tattoing, iv drug use,  
H/o CLD, DM, HT, CKD, CVD, DRUG INTAKE, THYROID 
DISORDERS , EPILEPSY , HEPATITIS.  
 
Personal history 
alcoholic/ non alcoholic 
smoker/ nonsmoker 
 Clinical Examination: 
Consciousness 
Orientation 
Afebrile /Febrile 
Pallor/no pallor 
Cyanosis/ No cyanosis 
Clubbing/No clubbing 
Pedal edema / no pedal edema  
Height : 
Weight : 
VITALS 
Temperature  
Pulse rate 
Blood pressure 
Respiratory rate 
Oxygen saturation 
SYSTEMIC EXAMINATION  
 
CARDIOVASCULAR SYSTEM : 
 
 
RESPIRATORY SYSTEM 
 
 
ABDOMEN 
 
 
CNS 
 
Diagnosis 
 
                                     
 
 
MASTER CHART 
S.No. 
ART 
No.  
AGE SEX 
CD4 
COUNT 
ON 
ART 
UREA CREATININE Na+ K+ 
URINE 
PROTEIN 
USG- ↑ 
renal 
cortical 
echoes  
1 18588 23 M 497 - 20 0.9 126 3.5 + - 
2 18566 47 M 1121 - 32 0.7 135 3.5 + - 
3 18587 38 F 763 - 16 1.2 122 4 + - 
4 18595 31 F 532 - 22 0.8 122 4.5 - - 
5 18597 44 M  1389 - 21 1 136 3.9 - - 
6 9909 25 M 180 + 46 1.4 144 3.7 + + 
7 18599 46 M 158 - 18 1.1 137 5.2 - - 
8 18629 55 M 458 - 24 0.6 120 4 - - 
9 18023 44 M 480 - 58 1.6 142 3.7 + + 
10 18639 23 F 572 - 30 0.9 125 4.1 + - 
11 18657 24 M 180 - 21 1 140 4.1 + - 
12 18690 30 M 576 - 26 1.2 136 4.2 - - 
13 18478 26 F 566 - 58 2.2 138 5.1 - + 
14 18456 34 M 132 - 28 1.1 120 4 - - 
15 18464 45 F 745 - 22 0.9 139 4.8 + - 
16 18485 28 F 640 - 21 1.2 135 3.5 - - 
17 18490 53 m 129 - 42 1.6 137 2.2 + - 
18 18495 40 F 745 - 40 0.9 132 2.1 - - 
19 18488 44 M 430 - 28 1.1 140 2.2 - - 
20 18525 44 F 1023 - 36 0.9 138 3 + - 
21 18533 48 M 656 - 32 1 122 5.2 - - 
22 18536 19 M 487 - 28 1.1 136 5 + - 
23 18539 25 F 563 - 30 0.7 140 2.2 - - 
24 18825 44 M 1023 - 52 1.7 136 4 + + 
25 9962 28 M 322 + 28 1.2 128 5 - - 
26 9963 69 F 97 + 24 0.9 145 5.6 - - 
27 9965 56 M 269 + 20 0.6 128 3.8 - - 
28 9969 26 M 312 + 18 1 130 3.5 + - 
29 9913 16 M 107 + 46 1.5 136 3.7 - + 
30 9974 37 F 155 + 16 0.7 137 3.2 - - 
31 9973 40 M 206 + 24 0.7 130 3.5 - - 
32 9967 35 M 396 + 58 1.9 135 3.7 + + 
33 9976 22 F 501 + 20 0.9 134 4 - - 
34 9977 29 M 287 + 26 1 128 5 - - 
35 9978 55 F 107 + 29 1.2 135 2.8 - - 
36 9980 27 M 325 + 38 1.1 137 5.6 + - 
37 18544 46 F 734 - 52 1.7 140 3.7 + + 
38 9981 35 F 256 + 30 1 138 3.5 - - 
39 9982 28 M 513 + 28 0.7 132 3.6 - - 
40 18566 31 F 532 - 60 1.8 144 4 - + 
41 9983 27 M 654 + 21 0.9 134 4.5 - - 
42 9940 45 M 89 + 18 0.6 124 5.5 - - 
43 9943 41 F 84 + 20 0.8 135 3.1 - - 
44 9945 29 F 442 + 16 1 130 5 - - 
45 9950 39 F 165 + 18 0.6 136 3.6 - - 
46 9952 43 M 72 + 24 1.2 142 4.2 - - 
47 18635 29 M 424 - 115 7.1 135 4.1 - + 
48 9953 56 F 295 + 26 0.8 140 5.6 - - 
49 9955 33 M 366 + 29 0.9 126 5 - - 
50 9956 21 F 74 + 19 0.7 145 2.7 - - 
51 9957 53 M 374 + 23 1.1 128 3.5 + - 
52 9959 19 M 378 + 22 1 135 3.9 + - 
53 9948 35 F 232 + 48 1.4 137 5.8 - + 
54 9960 39 M 407 + 25 1.2 140 3.5 - - 
55 18686 23 M 615 - 70 2 135 5.2 + + 
56 9961 25 F 458 + 27 0.7 130 4.2 - - 
57 18830 38 M 567 - 28 0.6 120 4.5 - - 
58 18840 35 M 566 - 32 0.7 126 4.1 - - 
59 18915 45 F 145 - 36 0.8 124 5 + - 
60 9949 22 M 240 + 67 1.7 135 3.5 - + 
61 18921 42 F 560 - 30 0.7 120 4.5 - - 
62 18924 18 M 1120 - 26 1.2 137 2.1 + - 
63 18938 36 M 364 - 22 1.1 126 3.5 - - 
64 9902 35 F 779 + 20 0.8 138 5.6 - - 
65 18703 36 M 1166 - 41 1.6 140 4.3 + - 
66 9904 35 F 522 + 18 1 135 3.4 - - 
67 9906 27 M 448 + 21 0.8 145 3 - - 
68 18706 24 M 743 - 31 0.6 132 3.7 - - 
69 18707 25 M 316 + 17 0.9 137 3.9 + - 
70 18709 45 F 302 - 19 1 120 4 + - 
71 18715 40 M 56 - 20 1.2 122 4.3 - - 
72 18722 21 F 1308 - 55 1.7 139 4.1 - + 
73 18727 50 M 474 - 24 1.1 122 4.3 - - 
74 18764 45 F 546 - 26 0.7 126 3.6 - - 
75 18798 25 F 516 - 32 1.2 135 2.2 - - 
76 18816 44 M 700 - 31 0.6 124 3.5 + - 
77 18828 37 M 586 - 19 0.8 139 4 - - 
78 10012 30 F 85 + 20 1 122 3.6 - - 
79 10013 26 F 352 + 21 0.7 128 4.1 - - 
80 10015 31 M 136 + 18 1.1 140 2.8 - - 
81 10016 30 F 401 + 23 0.9 136 3.4 - - 
82 18889 26 M 563 - 67 1.8 136 4.2 + + 
83 10017 42 F 430 + 17 0.7 142 3.7 - - 
84 18029 46 M 707 - 19 1.2 137 2.2 - - 
85 18035 55 M 740 - 23 1.1 130 4.3 - - 
86 18045 59 M 130 - 31 1 135 3.8 - - 
87 18047 42 M 866 - 30 0.7 138 4.4 - - 
88 18051 58 M 475 - 28 0.9 143 3.9 - - 
89 18930 40 F 179 - 65 1.9 137 5.1 + + 
90 18065 23 F 205 - 34 1.2 135 2.2 - - 
91 18077 33 M 442 - 32 1 120 3.5 - - 
92 18079 15 M 140 - 26 0.8 138 3.4 - - 
93 18304 52 M 640 - 61 1.9 140 3.8 + + 
94 18080 47 F 250 - 22 0.6 122 3 - - 
95 18092 43 M 951 - 20 0.7 132 4 + - 
96 18094 30 F 857 - 16 1.1 120 5.3 - - 
97 18098 33 F 831 - 18 1 136 4.5 + - 
98 9984 45 M 346 + 32 0.6 128 3.5 - - 
99 18812 35 M 1528 - 50 1.7 137 4.2 - + 
100 9985 52 F 81 + 28 1.2 140 5.1 - - 
101 9986 38 M 411 + 24 0.9 135 4.1 + - 
102 9989 49 M 356 + 16 0.6 132 4.4 - - 
103 9990 23 M 398 + 32 0.8 142 4.5 - - 
104 9992 31 M 435 + 20 1 130 5 - - 
105 9994 46 M 439 + 21 1.1 136 4.2 - - 
106 9995 25 F 437 + 22 1 126 3.5 - - 
107 9996 28 M 255 + 20 1.2 135 4 - - 
108 9997 52 M 314 + 18 0.8 145 5.2 - - 
109 9998 25 F 232 + 16 0.7 126 5 - - 
110 9999 38 F 242 + 21 1.1 137 3.8 - - 
111 9951 43 M 214 + 53 1.8 142 2.8 - + 
112 10001 37 F 345 + 20 0.6 145 3.5 - - 
113 10002 52 M 636 + 24 0.8 139 5.3 - - 
114 18328 42 M 320 - 60 1.8 137 3.2 + + 
115 10006 29 M 479 + 26 1.1 135 4 - - 
116 10007 40 M 975 + 28 1.2 140 5.4 - - 
117 10008 35 F 356 + 30 1 128 4.2 - - 
118 10011 41 M 140 + 31 0.6 142 4.1 - - 
119 18294 22 M 446 - 24 0.9 122 4.2 - - 
120 18299 33 M 78 - 26 1.2 120 3.6 - - 
121 18304 52 M 320 - 28 0.6 136 3.7 - - 
122 18306 53 M 340 - 22 1 140 4 - - 
123 18360 22 M 141 - 62 4.1 135 3.5 + + 
124 18312 35 F 1528 - 24 0.7 120 3.9 - - 
125 18319 46 M 456 - 30 1.1 128 4.8 - - 
126 18323 37 F 234 - 18 0.8 137 3 - - 
127 18327 57 M 556 - 26 1.2 122 4.5 - - 
128 18336 25 M 410 - 16 1 126 4.9 - - 
129 9991 57 F 435 + 55 1.7 137 4 + + 
130 18337 26 M 370 - 30 1.2 139 2.2 - - 
131 18344 45 F 146 - 18 0.8 140 2.1 - - 
132 18350 27 M 520 - 19 1.2 124 3.7 - - 
133 18352 38 M 198 - 16 0.6 122 5 - - 
134 18363 32 M 175 - 21 1.1 137 2.1 - - 
135 18364 57 M 483 - 26 0.7 126 4.6 - - 
136 18365 40 M 505 - 28 1 138 5 - - 
137 18366 49 M 419 - 24 1 140 3.8 - - 
138 18397 26 M 443 - 60 2.1 135 3.5 + + 
139 18374 48 M 430 - 30 0.8 140 2.2 - - 
140 18390 47 F 489 - 27 1 120 3.7 - - 
141 18398 45 F 288 - 18 1.1 139 2.2 - - 
142 18400 33 M 240 - 28 0.6 142 4.1 - - 
143 18427 50 M 435 - 16 1.2 138 4.5 - - 
144 18952 32 F 382 - 65 2.2 137 4.5 - + 
145 12600 43 M 832 - 20 1 135 2.4 - - 
146 93 27 F 84 - 30 0.6 120 5 - - 
147 1183 23 M 410 - 33 1 139 4.2 - - 
148 486 24 F 449 - 24 0.9 120 3.6 - - 
149 875 27 M 921 - 30 0.7 140 4 - - 
150 18218 36 F 198 - 26 0.8 135 3.9 - - 
151 18221 45 M 254 - 18 1 136 4.3 - - 
152 18227 40 F 230 - 16 1.1 141 4 - - 
153 18238 32 F 551 - 16 1 120 4.5 - - 
154 18240 40 M 338 - 30 0.8 124 3.5 - - 
155 18253 52 M 516 - 18 0.6 135 4.1 - - 
156 18264 36 M 587 - 19 0.7 141 4 - - 
157 18265 29 F 2588 - 20 1.1 142 2 - - 
158 18147 45 M 441 - 55 1.8 141 3.6 - + 
159 18269 30 F 725 - 29 1.2 120 3.5 - - 
160 18151 56 M 921 - 88 3 141 4 - - 
161 18272 45 M 600 - 32 0.7 147 2.2 - - 
162 18275 38 F 694 - 33 1 120 4.1 - - 
163 18276 48 M 608 - 23 0.8 139 2.1 - - 
164 18277 58 F 524 + 34 1 136 5.7 - - 
165 18291 48 M 474 - 25 1.2 135 5 - - 
166 18183 29 M 329 - 33 1.1 120 4.9 - - 
167 18205 35 M 440 - 63 1.8 136 4.7 - + 
168 18132 35 M 286 - 20 1.2 124 3.5 - - 
169 18135 21 M 666 - 18 1 135 2.2 - - 
170 18142 35 F 614 - 24 0.8 122 4.5 - - 
171 18148 33 M 1087 - 26 0.7 142 4 - - 
172 18152 45 F 1116 - 30 0.6 140 2.4 - - 
173 10000 39 M 255 + 82 2.1 140 5.1 - + 
174 18157 30 M 422 - 31 1 136 4.8 - - 
175 18226 39 M 1193 - 54 1.7 139 5 - + 
176 18160 24 M 627 - 34 1.1 138 3.8 - - 
177 18161 35 M 542 - 28 0.8 141 2.1 - - 
178 18187 42 M 555 - 18 1.2 132 3.6 - - 
179 18188 40 M 918 - 22 0.9 137 3.8 - - 
180 18196 28 M 622 - 20 1.1 138 2.2 - - 
181 18209 42 M 670 - 16 1 134 4 - - 
182 18214 50 M 670 - 18 1.2 135 4.2 - - 
183 18215 29 M 401 - 20 0.8 135 4.5 - - 
184 18270 52 M 632 - 58 1.8 139 2.1 - + 
185 9921 57 M 498 + 24 0.9 132 3.5 - - 
186 9922 30 F 108 + 18 1.2 137 3.2 - - 
187 9924 38 F 175 + 26 1 122 3.5 - - 
188 9925 36 F 207 + 29 0.7 124 3.6 - - 
189 9927 29 M 547 + 20 0.6 135 3 - - 
190 9929 28 M 723 + 30 1.1 138 3.7 - - 
191 9930 27 M 301 + 18 0.8 128 3.9 - - 
192 9931 40 M 321 + 34 0.9 139 4 + - 
193 9934 22 M 520 + 16 1 140 3.2 - - 
194 9935 17 M 883 + 20 1.2 134 5.8 - - 
195 9936 35 M 402 + 20 0.7 145 5 - - 
196 9937 56 M 139 + 32 0.6 124 4.2 - - 
197 10014 36 F 315 + 59 1.8 135 3.5 - + 
198 9938 35 F 139 + 20 1.2 145 3.8 + - 
199 9939 50 M 333 + 24 1 139 3 - - 
200 18277 31 M 474 - 60 2 140 2.4 - + 
 
 
 
 
 
 
 
 
  
 
  
 
 
 
 
 
 
